These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
448 related articles for article (PubMed ID: 37106442)
1. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma. Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442 [TBL] [Abstract][Full Text] [Related]
2. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma. Zhang F; Liu Y; Yang Y; Yang K BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731 [TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma. Jiang L; Yin X; Zhang H; Zhang X; Cao Z; Zhou M; Xu W Biomed Res Int; 2023; 2023():4444869. PubMed ID: 36814797 [TBL] [Abstract][Full Text] [Related]
4. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma. Li Z; Shen L; Li Y; Shen L; Li N Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984 [TBL] [Abstract][Full Text] [Related]
5. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma. Mao R; Chen Y; Xiong L; Liu Y; Zhang T Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878 [TBL] [Abstract][Full Text] [Related]
6. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma. Song D; Tian J; Han X; Li X Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165 [TBL] [Abstract][Full Text] [Related]
7. A nomogram based on a gene signature for predicting the prognosis of patients with head and neck squamous cell carcinoma. Yang B; Fu L; Xu S; Xiao J; Li Z; Liu Y Int J Biol Markers; 2019 Sep; 34(3):309-317. PubMed ID: 31452437 [TBL] [Abstract][Full Text] [Related]
9. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma. Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463 [TBL] [Abstract][Full Text] [Related]
10. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients. Huang Y; Liu Z; Zhong L; Wen Y; Ye Q; Cao D; Li P; Liu Y BMC Genomics; 2020 Oct; 21(1):691. PubMed ID: 33023466 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia-derived molecular subtype and gene signature characterize prognoses and therapeutic responses in head and neck squamous cell carcinoma. Zou J; Chu S; Zhou H; Zhang Y Medicine (Baltimore); 2024 Feb; 103(6):e37233. PubMed ID: 38335389 [TBL] [Abstract][Full Text] [Related]
12. A Signature of N Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X Front Immunol; 2022; 13():809872. PubMed ID: 35185897 [TBL] [Abstract][Full Text] [Related]
13. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma. Liu J; Lu J; Li W BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159 [TBL] [Abstract][Full Text] [Related]
14. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients. Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X Front Immunol; 2022; 13():1100417. PubMed ID: 36703967 [TBL] [Abstract][Full Text] [Related]
15. A pyroptosis-related gene expression signature predicts immune microenvironment and prognosis in head and neck squamous cell carcinoma. Zhou W; Feng M; Qi F; Qiao J; Fan L; Zhang L; Hu X; Huang C Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):953-963. PubMed ID: 38063904 [TBL] [Abstract][Full Text] [Related]
16. Development of Chromatin Regulator-related Molecular Subtypes and a Signature to Predict Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma. Huang J; Xu Z; Wang Z; Zhou C; Shen Y Curr Cancer Drug Targets; 2024; 24(8):804-819. PubMed ID: 38310463 [TBL] [Abstract][Full Text] [Related]
17. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
18. Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma. Huang C; Liang Y; Dong Y; Huang L; Li A; Du R; Huang H Front Cell Dev Biol; 2022; 10():884590. PubMed ID: 36081907 [No Abstract] [Full Text] [Related]
19. Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma. Yang F; Zhou LQ; Yang HW; Wang YJ Front Genet; 2022; 13():927614. PubMed ID: 36092911 [No Abstract] [Full Text] [Related]
20. Telomere maintenance genes-derived prognosis signature characterizes immune landscape and predicts prognosis of head and neck squamous cell carcinoma. Zou J; Chu S; Bao Q; Zhang Y Medicine (Baltimore); 2023 Aug; 102(31):e34586. PubMed ID: 37543795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]